Hyoscyamine

BreastfeedingGeriatricPediatric
  • TRADE NAMES: Anaspaz; Cytospaz; Donnamar; Duboisine; ED-SPAZ; Egacene Durettes; Egazil; Gastrosed; Hyco; Hycosol Sl; Hyospaz; IB-Stat (InKline); Levbid (Schwarz); Levsin (Schwarz); Levsin/SL (Schwarz); Levsinex (Schwarz); Medispaz; Nulev (Schwarz); Pasmex; Peptard; Setamine; Urised
  • INDICATIONS: Treatment of gastrointestinal tract disorders caused by spasm, adjunctive therapy for peptic ulcers, cystitis, Parkinsonism, biliary and renal colic
  • CLASS: Anticholinergic, Muscarinic antagonist
  • HALF-LIFE: N/A
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Anticholinergics, Arbutamine

PREGNANCY CATEGORY: C

Our database has 16 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
LOCAL.
OCULAR.
OTHER.


Page last updated 08/02/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top